| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| S-Nitrosoglutathione | 16 | 2021 | 87 | 5.070 |
Why?
|
| Neuroprotective Agents | 14 | 2019 | 317 | 2.950 |
Why?
|
| Recovery of Function | 7 | 2021 | 506 | 2.650 |
Why?
|
| Alcohol Dehydrogenase | 3 | 2021 | 32 | 2.120 |
Why?
|
| Nitric Oxide | 9 | 2019 | 382 | 1.600 |
Why?
|
| Peroxynitrous Acid | 6 | 2018 | 55 | 1.590 |
Why?
|
| Enzyme Inhibitors | 9 | 2021 | 659 | 1.570 |
Why?
|
| Pyrroles | 3 | 2021 | 83 | 1.520 |
Why?
|
| Benzamides | 4 | 2021 | 156 | 1.500 |
Why?
|
| Brain Injuries | 4 | 2016 | 268 | 1.430 |
Why?
|
| Disease Models, Animal | 17 | 2020 | 2550 | 1.270 |
Why?
|
| Brain | 15 | 2019 | 2176 | 1.230 |
Why?
|
| Infarction, Middle Cerebral Artery | 7 | 2019 | 105 | 1.140 |
Why?
|
| Adrenoleukodystrophy | 7 | 2015 | 45 | 1.110 |
Why?
|
| Spinal Cord Injuries | 6 | 2021 | 551 | 1.110 |
Why?
|
| Rats, Sprague-Dawley | 23 | 2018 | 2083 | 1.100 |
Why?
|
| Stroke | 6 | 2020 | 2163 | 1.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2016 | 71 | 1.040 |
Why?
|
| Caffeic Acids | 3 | 2018 | 9 | 1.030 |
Why?
|
| Phenylethyl Alcohol | 3 | 2018 | 9 | 1.030 |
Why?
|
| Animals | 49 | 2021 | 20881 | 0.930 |
Why?
|
| Inflammation | 11 | 2021 | 1030 | 0.880 |
Why?
|
| Nerve Regeneration | 2 | 2015 | 42 | 0.870 |
Why?
|
| Rats | 30 | 2016 | 5300 | 0.840 |
Why?
|
| Blood-Brain Barrier | 6 | 2021 | 99 | 0.810 |
Why?
|
| Nitric Oxide Synthase Type I | 3 | 2018 | 35 | 0.800 |
Why?
|
| Aldehyde Dehydrogenase, Mitochondrial | 2 | 2021 | 21 | 0.790 |
Why?
|
| Mice, Inbred C57BL | 12 | 2021 | 2791 | 0.750 |
Why?
|
| Fatty Acids | 9 | 2015 | 222 | 0.740 |
Why?
|
| Oxidative Stress | 7 | 2011 | 718 | 0.720 |
Why?
|
| Calpain | 2 | 2018 | 205 | 0.700 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2018 | 105 | 0.700 |
Why?
|
| Brain Ischemia | 5 | 2015 | 665 | 0.660 |
Why?
|
| Lipopolysaccharides | 6 | 2016 | 455 | 0.650 |
Why?
|
| NF-kappa B | 6 | 2018 | 432 | 0.650 |
Why?
|
| Nitric Oxide Donors | 2 | 2011 | 54 | 0.640 |
Why?
|
| Nitrosoguanidines | 1 | 2018 | 4 | 0.640 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 5 | 2021 | 133 | 0.640 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2019 | 102 | 0.640 |
Why?
|
| Peroxisomes | 7 | 2019 | 48 | 0.620 |
Why?
|
| Guanylate Cyclase | 1 | 2018 | 25 | 0.610 |
Why?
|
| Endothelium, Vascular | 2 | 2020 | 371 | 0.590 |
Why?
|
| Random Allocation | 6 | 2016 | 442 | 0.550 |
Why?
|
| Mice | 18 | 2021 | 8474 | 0.550 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 167 | 0.540 |
Why?
|
| Adenylate Kinase | 1 | 2015 | 10 | 0.520 |
Why?
|
| Polyradiculopathy | 1 | 2015 | 6 | 0.510 |
Why?
|
| Arachidonate 5-Lipoxygenase | 3 | 2015 | 14 | 0.500 |
Why?
|
| Arachidonic Acids | 1 | 2015 | 97 | 0.500 |
Why?
|
| Lovastatin | 4 | 2008 | 78 | 0.500 |
Why?
|
| Astrocytes | 9 | 2015 | 270 | 0.480 |
Why?
|
| Ischemic Attack, Transient | 2 | 2007 | 167 | 0.480 |
Why?
|
| Vasodilator Agents | 1 | 2015 | 138 | 0.470 |
Why?
|
| Aging | 1 | 2020 | 911 | 0.470 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 219 | 0.460 |
Why?
|
| Antioxidants | 5 | 2018 | 304 | 0.460 |
Why?
|
| Signal Transduction | 5 | 2019 | 2689 | 0.450 |
Why?
|
| Acute Kidney Injury | 1 | 2016 | 232 | 0.450 |
Why?
|
| Sepsis | 1 | 2016 | 233 | 0.440 |
Why?
|
| Reperfusion Injury | 4 | 2015 | 320 | 0.430 |
Why?
|
| Neurons | 6 | 2018 | 881 | 0.420 |
Why?
|
| Male | 22 | 2021 | 37321 | 0.420 |
Why?
|
| Nitric Oxide Synthase Type II | 11 | 2016 | 201 | 0.410 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2016 | 234 | 0.390 |
Why?
|
| Kidney | 1 | 2016 | 945 | 0.390 |
Why?
|
| Mice, Knockout | 6 | 2021 | 1692 | 0.380 |
Why?
|
| Plasmalogens | 2 | 2008 | 8 | 0.380 |
Why?
|
| Glutathione | 5 | 2016 | 343 | 0.370 |
Why?
|
| Reactive Oxygen Species | 4 | 2009 | 499 | 0.360 |
Why?
|
| Arginine | 2 | 2021 | 102 | 0.360 |
Why?
|
| Brain Infarction | 2 | 2012 | 54 | 0.350 |
Why?
|
| Phospholipases A2, Secretory | 1 | 2009 | 3 | 0.350 |
Why?
|
| Psychosine | 2 | 2008 | 33 | 0.330 |
Why?
|
| Leukodystrophy, Globoid Cell | 2 | 2008 | 27 | 0.330 |
Why?
|
| Behavior, Animal | 3 | 2019 | 470 | 0.310 |
Why?
|
| Cerebrum | 1 | 2008 | 20 | 0.310 |
Why?
|
| Endothelial Cells | 4 | 2018 | 384 | 0.310 |
Why?
|
| Nitric Oxide Synthase | 7 | 2005 | 163 | 0.310 |
Why?
|
| Encephalitis | 2 | 2008 | 43 | 0.300 |
Why?
|
| PPAR alpha | 4 | 2019 | 31 | 0.300 |
Why?
|
| Neuroglia | 2 | 2005 | 136 | 0.300 |
Why?
|
| Free Radical Scavengers | 3 | 2008 | 112 | 0.290 |
Why?
|
| Cell Line | 6 | 2016 | 1752 | 0.280 |
Why?
|
| Brain Edema | 3 | 2019 | 50 | 0.280 |
Why?
|
| Protective Agents | 1 | 2006 | 36 | 0.260 |
Why?
|
| Acetylcysteine | 4 | 2008 | 296 | 0.260 |
Why?
|
| Cells, Cultured | 12 | 2018 | 2673 | 0.250 |
Why?
|
| Oligodendroglia | 5 | 2015 | 107 | 0.250 |
Why?
|
| Oxidation-Reduction | 6 | 2018 | 567 | 0.250 |
Why?
|
| Lipid Peroxidation | 3 | 2011 | 94 | 0.250 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2020 | 115 | 0.240 |
Why?
|
| Benzodioxoles | 2 | 2021 | 30 | 0.230 |
Why?
|
| Multiple Sclerosis | 2 | 2021 | 132 | 0.230 |
Why?
|
| Tyrosine | 3 | 2018 | 196 | 0.230 |
Why?
|
| Phosphorylation | 3 | 2015 | 1200 | 0.220 |
Why?
|
| ATP-Binding Cassette Transporters | 5 | 2013 | 120 | 0.220 |
Why?
|
| Lipids | 3 | 2018 | 298 | 0.210 |
Why?
|
| Cytokines | 5 | 2021 | 866 | 0.210 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2016 | 1745 | 0.200 |
Why?
|
| Cyclooxygenase 2 | 2 | 2015 | 160 | 0.200 |
Why?
|
| Motor Activity | 2 | 2015 | 621 | 0.200 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2021 | 16 | 0.190 |
Why?
|
| Inflammation Mediators | 4 | 2008 | 244 | 0.180 |
Why?
|
| Myeloid Cells | 1 | 2021 | 57 | 0.180 |
Why?
|
| Lymphocytes | 1 | 2021 | 228 | 0.180 |
Why?
|
| Fibroblasts | 4 | 2015 | 902 | 0.180 |
Why?
|
| Hypoxia | 1 | 2021 | 169 | 0.180 |
Why?
|
| Th17 Cells | 1 | 2021 | 116 | 0.180 |
Why?
|
| Apoptosis | 6 | 2013 | 1641 | 0.180 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2018 | 48 | 0.170 |
Why?
|
| Organelle Biogenesis | 1 | 2019 | 34 | 0.170 |
Why?
|
| Autoimmune Diseases | 1 | 2021 | 186 | 0.170 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2012 | 160 | 0.170 |
Why?
|
| Membrane Proteins | 3 | 2018 | 617 | 0.170 |
Why?
|
| Locomotion | 3 | 2015 | 135 | 0.170 |
Why?
|
| Cerebrovascular Disorders | 1 | 2020 | 182 | 0.160 |
Why?
|
| Dynamins | 1 | 2018 | 14 | 0.160 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2019 | 87 | 0.160 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2018 | 10 | 0.160 |
Why?
|
| Behavior Rating Scale | 1 | 2018 | 7 | 0.160 |
Why?
|
| GTP Phosphohydrolases | 1 | 2018 | 46 | 0.160 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2018 | 51 | 0.160 |
Why?
|
| Heme Oxygenase-1 | 1 | 2018 | 40 | 0.160 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 236 | 0.160 |
Why?
|
| Caspase 3 | 2 | 2016 | 233 | 0.150 |
Why?
|
| Hyperalgesia | 2 | 2015 | 18 | 0.150 |
Why?
|
| Drug Synergism | 1 | 2018 | 260 | 0.150 |
Why?
|
| Superoxides | 1 | 2018 | 70 | 0.150 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 113 | 0.150 |
Why?
|
| Superoxide Dismutase | 1 | 2018 | 149 | 0.150 |
Why?
|
| Liver | 3 | 2019 | 1118 | 0.150 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2012 | 212 | 0.150 |
Why?
|
| Immunohistochemistry | 5 | 2012 | 1174 | 0.150 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2018 | 284 | 0.140 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 176 | 0.140 |
Why?
|
| Administration, Oral | 2 | 2015 | 411 | 0.140 |
Why?
|
| Blood Urea Nitrogen | 1 | 2016 | 65 | 0.140 |
Why?
|
| Protein Stability | 1 | 2016 | 90 | 0.140 |
Why?
|
| Microglia | 2 | 2009 | 143 | 0.140 |
Why?
|
| Acyl-CoA Oxidase | 3 | 2011 | 12 | 0.140 |
Why?
|
| Motor Skills | 1 | 2016 | 88 | 0.130 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 1293 | 0.130 |
Why?
|
| Creatinine | 1 | 2016 | 243 | 0.130 |
Why?
|
| Interleukin-10 | 1 | 2016 | 144 | 0.130 |
Why?
|
| Models, Biological | 3 | 2015 | 981 | 0.130 |
Why?
|
| Nociception | 1 | 2015 | 5 | 0.130 |
Why?
|
| Leukotriene B4 | 1 | 2015 | 17 | 0.130 |
Why?
|
| Lysophosphatidylcholines | 1 | 2015 | 11 | 0.130 |
Why?
|
| Blotting, Western | 3 | 2011 | 954 | 0.130 |
Why?
|
| Cell Differentiation | 4 | 2021 | 1034 | 0.130 |
Why?
|
| Analysis of Variance | 2 | 2015 | 1040 | 0.130 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2014 | 52 | 0.130 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2013 | 116 | 0.130 |
Why?
|
| Middle Cerebral Artery | 1 | 2015 | 57 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2016 | 626 | 0.120 |
Why?
|
| Humans | 17 | 2021 | 68618 | 0.120 |
Why?
|
| Receptor, trkB | 2 | 2012 | 27 | 0.120 |
Why?
|
| Vitamin E | 2 | 2004 | 55 | 0.120 |
Why?
|
| Cell Proliferation | 3 | 2015 | 1174 | 0.120 |
Why?
|
| Dinoprostone | 1 | 2015 | 110 | 0.120 |
Why?
|
| Urinary Bladder Diseases | 1 | 2014 | 26 | 0.120 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 86 | 0.120 |
Why?
|
| Gene Expression | 1 | 2016 | 770 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 164 | 0.120 |
Why?
|
| Cerebrovascular Circulation | 2 | 2007 | 296 | 0.120 |
Why?
|
| Gene Silencing | 2 | 2011 | 137 | 0.110 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2012 | 124 | 0.110 |
Why?
|
| Mitochondria | 1 | 2018 | 643 | 0.110 |
Why?
|
| RNA, Small Interfering | 3 | 2010 | 434 | 0.110 |
Why?
|
| Child | 5 | 2015 | 6405 | 0.110 |
Why?
|
| Female | 11 | 2021 | 38074 | 0.110 |
Why?
|
| Cauda Equina | 1 | 2012 | 3 | 0.110 |
Why?
|
| Edema | 2 | 2011 | 66 | 0.110 |
Why?
|
| Spinal Stenosis | 1 | 2012 | 12 | 0.110 |
Why?
|
| Simvastatin | 1 | 2012 | 34 | 0.110 |
Why?
|
| Spinal Cord Compression | 1 | 2012 | 23 | 0.110 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2012 | 160 | 0.110 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 597 | 0.100 |
Why?
|
| Neoplasm Proteins | 2 | 2012 | 307 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 710 | 0.100 |
Why?
|
| Amenorrhea | 1 | 2011 | 16 | 0.100 |
Why?
|
| Reperfusion | 1 | 2012 | 78 | 0.100 |
Why?
|
| Molsidomine | 1 | 2011 | 5 | 0.100 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2011 | 17 | 0.100 |
Why?
|
| Synaptophysin | 1 | 2011 | 16 | 0.100 |
Why?
|
| Hydroxamic Acids | 1 | 2011 | 84 | 0.090 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 148 | 0.090 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2010 | 7 | 0.090 |
Why?
|
| Leukotrienes | 1 | 2010 | 13 | 0.090 |
Why?
|
| Ceramides | 2 | 2004 | 578 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2010 | 282 | 0.090 |
Why?
|
| Cell Membrane | 2 | 2009 | 525 | 0.090 |
Why?
|
| Exercise Therapy | 1 | 2012 | 183 | 0.090 |
Why?
|
| PC12 Cells | 1 | 2009 | 36 | 0.090 |
Why?
|
| Membrane Lipids | 1 | 2009 | 31 | 0.090 |
Why?
|
| Oxidoreductases | 1 | 2010 | 117 | 0.080 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2009 | 84 | 0.080 |
Why?
|
| RNA, Messenger | 4 | 2011 | 1664 | 0.080 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2012 | 92 | 0.080 |
Why?
|
| Chemokine CCL22 | 1 | 2008 | 6 | 0.080 |
Why?
|
| Coculture Techniques | 2 | 2008 | 147 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2011 | 7029 | 0.080 |
Why?
|
| Membrane Microdomains | 1 | 2008 | 32 | 0.080 |
Why?
|
| Multienzyme Complexes | 1 | 2008 | 50 | 0.080 |
Why?
|
| Catalase | 2 | 2004 | 85 | 0.080 |
Why?
|
| Time Factors | 4 | 2012 | 4655 | 0.070 |
Why?
|
| Mice, Transgenic | 3 | 2020 | 1033 | 0.070 |
Why?
|
| Stem Cells | 2 | 2008 | 248 | 0.070 |
Why?
|
| Neuropsychological Tests | 1 | 2009 | 517 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2011 | 334 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 700 | 0.070 |
Why?
|
| Polyethylene Glycols | 1 | 2008 | 149 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2007 | 100 | 0.070 |
Why?
|
| Biomarkers | 2 | 2015 | 1593 | 0.070 |
Why?
|
| Glutathione Disulfide | 1 | 2006 | 31 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2005 | 1851 | 0.070 |
Why?
|
| Macrophages | 1 | 2009 | 647 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 2223 | 0.070 |
Why?
|
| Lipoxygenase | 1 | 2005 | 13 | 0.060 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2005 | 23 | 0.060 |
Why?
|
| Phospholipases A | 1 | 2005 | 41 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2006 | 173 | 0.060 |
Why?
|
| Zellweger Syndrome | 1 | 2004 | 14 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2006 | 420 | 0.060 |
Why?
|
| Permeability | 1 | 2005 | 131 | 0.060 |
Why?
|
| Peroxisomal Disorders | 1 | 2004 | 16 | 0.060 |
Why?
|
| Ectodysplasins | 1 | 2004 | 7 | 0.060 |
Why?
|
| Tetrazolium Salts | 1 | 2004 | 36 | 0.060 |
Why?
|
| Lactosylceramides | 1 | 2004 | 27 | 0.060 |
Why?
|
| Proline | 1 | 2004 | 52 | 0.060 |
Why?
|
| DNA Fragmentation | 1 | 2004 | 85 | 0.060 |
Why?
|
| Anticholesteremic Agents | 1 | 2004 | 49 | 0.060 |
Why?
|
| Neurologic Examination | 1 | 2004 | 107 | 0.060 |
Why?
|
| Regional Blood Flow | 1 | 2004 | 168 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2004 | 107 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2005 | 314 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2004 | 230 | 0.060 |
Why?
|
| Down-Regulation | 3 | 2011 | 447 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 2004 | 241 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2004 | 191 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 290 | 0.050 |
Why?
|
| Acetyltransferases | 2 | 2013 | 49 | 0.050 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2012 | 35 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2004 | 183 | 0.050 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2021 | 17 | 0.050 |
Why?
|
| Pertussis Toxin | 1 | 2021 | 72 | 0.050 |
Why?
|
| Cellular Microenvironment | 1 | 2021 | 10 | 0.050 |
Why?
|
| Aldehydes | 1 | 2021 | 34 | 0.050 |
Why?
|
| Enzyme Induction | 3 | 2005 | 119 | 0.050 |
Why?
|
| Disease Progression | 2 | 2019 | 1038 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 226 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 329 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2019 | 114 | 0.040 |
Why?
|
| Morpholines | 2 | 2012 | 79 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2011 | 137 | 0.040 |
Why?
|
| Isoenzymes | 2 | 2010 | 308 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2015 | 32 | 0.030 |
Why?
|
| Rats, Inbred Lew | 2 | 2005 | 150 | 0.030 |
Why?
|
| Cell Death | 2 | 2008 | 329 | 0.030 |
Why?
|
| Cystitis | 1 | 2014 | 18 | 0.030 |
Why?
|
| Urination Disorders | 1 | 2014 | 20 | 0.030 |
Why?
|
| Contusions | 1 | 2014 | 11 | 0.030 |
Why?
|
| Myelin Sheath | 2 | 2005 | 115 | 0.030 |
Why?
|
| Urodynamics | 1 | 2014 | 43 | 0.030 |
Why?
|
| Sphingomyelins | 2 | 2004 | 106 | 0.030 |
Why?
|
| Proteinuria | 1 | 2014 | 136 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 242 | 0.030 |
Why?
|
| Urinary Bladder | 1 | 2014 | 108 | 0.030 |
Why?
|
| Evans Blue | 1 | 2012 | 4 | 0.030 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2012 | 4 | 0.030 |
Why?
|
| Transfection | 2 | 2005 | 782 | 0.030 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2012 | 25 | 0.030 |
Why?
|
| Nitrites | 1 | 2012 | 53 | 0.030 |
Why?
|
| E-Selectin | 1 | 2012 | 44 | 0.030 |
Why?
|
| Physical Stimulation | 1 | 2012 | 67 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 127 | 0.030 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2012 | 29 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2012 | 25 | 0.030 |
Why?
|
| Postural Balance | 1 | 2012 | 93 | 0.030 |
Why?
|
| Chromones | 1 | 2012 | 33 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 306 | 0.030 |
Why?
|
| Estrogen Receptor beta | 1 | 2011 | 19 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 280 | 0.020 |
Why?
|
| Estrous Cycle | 1 | 2011 | 23 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1553 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2012 | 328 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2012 | 240 | 0.020 |
Why?
|
| Acetylation | 1 | 2011 | 94 | 0.020 |
Why?
|
| Analgesics | 1 | 2012 | 118 | 0.020 |
Why?
|
| Transgenes | 1 | 2011 | 92 | 0.020 |
Why?
|
| Nervous System | 1 | 2011 | 45 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 282 | 0.020 |
Why?
|
| Ovary | 1 | 2011 | 99 | 0.020 |
Why?
|
| Connexin 43 | 1 | 2011 | 62 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 302 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 2011 | 107 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 567 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2011 | 99 | 0.020 |
Why?
|
| Docosahexaenoic Acids | 1 | 2010 | 12 | 0.020 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2010 | 29 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2010 | 231 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2015 | 2455 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2010 | 93 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 254 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2011 | 205 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2012 | 597 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 689 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 786 | 0.020 |
Why?
|
| Skin | 1 | 2011 | 451 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2008 | 251 | 0.020 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2008 | 35 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 1083 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 498 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 1447 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2008 | 396 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2008 | 186 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 1851 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2008 | 324 | 0.020 |
Why?
|
| Phospholipases A2 | 1 | 2005 | 32 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 2005 | 86 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 60 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2005 | 189 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2005 | 191 | 0.020 |
Why?
|
| Freund's Adjuvant | 1 | 2004 | 7 | 0.020 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2004 | 14 | 0.020 |
Why?
|
| Galactosyltransferases | 1 | 2004 | 7 | 0.020 |
Why?
|
| Thiocarbamates | 1 | 2004 | 20 | 0.020 |
Why?
|
| Acyltransferases | 1 | 2004 | 40 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2004 | 47 | 0.010 |
Why?
|
| Free Radicals | 1 | 2004 | 65 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2004 | 83 | 0.010 |
Why?
|
| Microarray Analysis | 1 | 2004 | 63 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 226 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 171 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2004 | 155 | 0.010 |
Why?
|
| Demyelinating Diseases | 1 | 2004 | 57 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2005 | 305 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2003 | 48 | 0.010 |
Why?
|
| Gliosis | 1 | 2003 | 51 | 0.010 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2003 | 49 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2003 | 358 | 0.010 |
Why?
|
| Temperature | 1 | 2004 | 341 | 0.010 |
Why?
|
| Glioma | 1 | 2004 | 140 | 0.010 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2004 | 86 | 0.010 |
Why?
|
| Chemokines | 1 | 2003 | 119 | 0.010 |
Why?
|
| Cell Movement | 1 | 2005 | 630 | 0.010 |
Why?
|
| Cell Survival | 1 | 2005 | 901 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 248 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 742 | 0.010 |
Why?
|
| Cholesterol | 1 | 2003 | 331 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2003 | 682 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2003 | 384 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2004 | 753 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2004 | 565 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 21403 | 0.010 |
Why?
|